ResearchThe Manchester Vision Regeneration (MVR) Lab was established at the Manchester Royal Eye Hospital in 2010 by Professor Paulo Stanga (Director). In 2013, clinical and research activities began at the NIHR/Wellcome Trust Manchester CRF.

The MVR Lab research team focus on developing research in Medical Retina and Vitreoretinal conditions using the most advanced diagnostic and treatment devices in order to offer the best options for clinical care, to improve patient health, as well as benefit the NHS. The MVR Lab is equipped with the latest diagnostic and research resources including Optomap® digital wide-angle multispectral imaging, 3D Fourier-Domain as well as the new Infra-Red Swept Source Optical Coherence Tomography (SS-OCT), Green and Yellow wavelength Pascal® laser with Endpoint Management® for subthreshold treatment.

The team is pioneering research into, amongst others, laser-tissue interaction, Swept Source OCT imaging of the cortical vitreous, Wide-Field OPTOS imaging vs. Standard ETDRS Photography, Anti-VEGF vs. PASCAL® laser therapy for diabetic macular oedema, development of an ultrasound-based probe for the surgical excision of vitreous and epiretinal membranes, Electronic Epiretinal Implants for artificial vision in patients with Retinitis Pigmentosa and Age-related Macular Degeneration and Stem-Cell treatment in Stargard’s Disease and Dry Age-related Macular Degeneration. The MVR Lab is the only site worldwide for some of these industry-sponsored research projects.

The MVR Lab is running the world’s first ever feasibility study that aims to establish whether partially sighted patients with loss of central vision due to the Dry form of Age-Related Macular Degeneration could benefit from an electronic retinal implant – the Argus® II Retinal Prosthesis System. This is also known as the “bionic eye” study in AMD. Professor Stanga leads the study in clinics at the Manchester Royal Eye Hospital and National Institute for Health Research (NIHR)/Wellcome Trust Manchester Clinical Research Facility.

The MVR Lab has written agreements of scientific collaboration in place with academics, research teams and Universities in the UK, USA, Italy, Spain, The Netherlands, Argentina, and Egypt, amongst others. National and overseas clinicians and researches frequently visit MVR Lab as Observers.

The MVR Lab has an independent Clinical Research Fellowship Program with four posts and various Observerships along the year.

For information regarding the research of Professor Stanga and whether you are a suitable candidate for any of our trials, please contact: Danielle Ridyard on 0 (+44) 1617 017691.